您目前的位置: 首页» 师资队伍» 在职教职工» 医学伦理与法律系

陈海丹

 

 

姓名

陈海丹

出生年

1979年

研究领域

生命伦理学、科技与社会(STS)

电子邮件

chenhaidan@bjmu.edu.cn

学位

博士

职称

长聘副教授

教育经历

浙江大学 哲学博士(2009)

 

工作经历

2009-2012 浙江大学人文学院  博士后

2012-2013 新加坡国立大学亚洲研究院  博士后

2013-2019 中国农业大学人文与发展学院  副教授、教授

2016-2017 斯坦福大学生物医学伦理学中心富布赖特访问学者

 

 

 

 

学术团体任职

Science, Technology and Society 协作主编(2014-2017)

East Asian Science, Technology and Society: an International Journal 书评编辑(2012-2014)、顾问委员会委员(2015至今)

The Hinxton Group: An International Consortium on Stem Cells, Ethics & Law(国际干细胞、伦理和法律联盟成员)(2010至今)

中华医学会医学伦理学分会第八届委员会国际合作与交流学组委员(2018至今)

中国自然辨证法研究会生命伦理学专业委员会理事(2016-2018)、常务理事(2018至今)

中国社会学会科学社会学专业委员会理事(2015至今)

中国遗传学会科学道德与伦理委员会委员(2014至今)

校内开设课程

生命伦理学前沿问题专题研究(研究生课程)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

学术论文

英文:

1.Margaret Sleeboom-Faulkner*, Haidan Chen and Acim Rosemann, 2018, Regulatory capacity building and the governance of clinical stem cell research in China, Science and Public Policy , 45(3), 416-427. (SSCI)

2.Haidan Chen*, 2017, Reflection on the governance of clinical stem cell research and applications in China, Regenerative Medicine , 12(6), 593–597. (SCI)

3.Lan Lü and Haidan Chen*, 2016, Chinese Public’s Risk Perceptions of Genetically Modified Food: From the 1990s to 2015. Science, Technology, and Society . 21(1), 110-128. (SSCI)

4.Haidan Chen*, 2016, Book Review People’s Science: Bodies and Rights on the Stem Cell Frontier, New Genetics and Society , 35(1), 97-99. (SSCI/SCI)

5.Haidan Chen*, Benny Chan, and Yann Joly, 2015, Privacy and Biobanking in China: A Case of Policy in Transition. Journal of Law, Medicine & Ethics . 43(4), 726-742. (SSCI/SCI)

6.Haidan Chen* and Tikki Pang, 2015, Human Genomics in Asia. In: James D. Wright (editor-in-chief), International Encyclopedia of the Social & Behavioral Sciences , 2nd edition, Vol 11. Oxford: Elsevier, pp. 318–322.

7.Haidan Chenand Tikki Pang*, 2015, A Call for Global Governance of Biobanks, Bulletin of World Health Organization , 93, 113-117. (SCI)

8.Haidan Chen*, 2014, BIONET: Herbert’s Road Toward China, in Valediction for Herbert Gottweis, BioSocieties , 9(4), 475-477. (SSCI)

9.Johannes Starkbaum*, Haidan Chen and Herbert Gottweis, 2014, Publics and Biobanks in China and Europe: A Comparative Perspective. Asia Europe Journal , 12(3), 345-359. (SSCI)

10.Haidan Chen*, 2013, Governing International Biobank Collaboration: A Case Study of China Kadoorie Biobank, Science, Technology and Society , 18(3), 321-338. (SSCI)

11.Gregory Clancey* and Haidan Chen (special issue guest editors), 2013, Asian Biopoleis: Biomedical Research in ‘The Asian Century’,  Science, Technology and Society , 18(3), 267-273. (SSCI)

12. Haidan Chen*, Herbert Gottweis and Johannes Starkbaum, 2013, Public Perceptions of Biobanks in China: A Focus Group Study, Biopreservation and Biobanking, 11(5), 267-271. (SSCI/SCI)

13.Haidan Chenand Herbert Gottweis*, 2013, Stem Cell Treatment in China: Rethinking the Patient Role in the Global Bio-Economy, Bioethics , 27(4), 194-207. (SSCI)

14.Ayo Wahlberg*, Christoph Rehmann-Sutter, Margaret Sleeboom-Faulkner, Guangxiu Lu, Ole D?ring, Yali Cong, Alicja Laska-Formejster, Jing He, Haidan Chen, Herbert Gottweis and Nikolas Rose, 2013, From Global Bioethics to Ethical Governance of Biomedical Research Collaborations, Social Science and Medicine , 98, 293-300. (SSCI)

15.Christian Haddad*, Haidan Chen and Herbert Gottweis, 2013, Unruly Objects: Novel Innovation Paths and Their Regulatory Challenge. In Andrew Webster (editor), The Global Dynamics of Regenerative Medicine: A Social Science Critique , Palgrave Macmillan, pp. 88-117.

16.Herbert Gottweis*, Haidan Chen and Johannes Starkbaum, 2011, Biobanks and the Phantom Public, Human Genetics , 130(3), 433-440. (SCI)

17.Haidan Chen*, 2011, Cord Blood Banking in China: Public and Private Tensions, East Asian Science, Technology and Society: an International Journal , 5, 329-339.

18.Haidan Chen*, 2009, Stem Cell Governance in China: From Bench to Bedside? New Genetics and Society , 28(3), 267-282. (SSCI)

中文:

19.陈海丹*,2019,伦理争论和科技治理:以英国胚胎和干细胞研究为例,《自然辩证法通讯》,已录用.(CSSCI)

20.陈海丹*,2018,干细胞临床研究政策回顾和展望,《自然辩证法通讯》,40(3),81-86.(CSSCI)

21.陈海丹*,2013,从共生产视角看中国干细胞治理,《自然辩证法通讯》,35(2),112-117.(CSSCI)

22.盛晓明*,陈海丹,2007,从实验室研究看认知文化,《科学学研究》,25(6),1041-1046.(CSSCI)

学术译著

瑟乔?西斯蒙多.《科学技术学导论》. 许为民 孟强 崔海灵 陈海丹译. 上海: 上海世纪出版集团. 2007.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

科研课题

国内课题

1.国家社科基金一般项目:个体化医学的伦理和社会问题研究(2015-2018)负责人

2.中央高校基本科研业务费专项引进人才支持计划项目:转化医学的治理问题研究(2013-2016)负责人

3.教育部人文社会科学青年项目:生物银行的治理问题研究(2011-2013)负责人

4.国家博士后面上资助项目:生物银行的治理问题研究(2009-2011)负责人

国际课题

1.新加坡国立大学李光耀公共政策学院资助项目:生物样本库的全球治理Global Governance of Biobanks(2014-2015) (共同负责人Co-PI with Tikki Pang)

2. 参与美国国立卫生研究院(NIH)资助项目:国际直接面向参与者的基因组研究的管理Regulation of International Direct-to-Participant Genomic Research(2018-2021)

3.    参与加拿大国际发展研究中心(IDRC)资助项目:家禽养殖小区对改善小型饲养户生计的生态健康评估 Eco-Health Assessment on Poultry Production Clusters (PPCs) for the Livelihood Improvement of Small-scale Poultry Producers(2011-2014)

4.    参与美国国立卫生研究院(NIH)资助项目:协调隐私法促进国际生物样本库研究Harmonizing Privacy Laws to Enable International Biobank Research (2014-2016)

5.    参与英国经济社会研究理事会资助项目:全球生物医学创新治理的国家策略:中国和印度的影响State Strategies of Governance in Global Biomedical Innovation: the Impact of China and India (II)(2012-2015)

6.参与新加坡国立大学和新加坡教育部项目:Asia Biopoleis: Biotechnology & Biomedicine as Emergent Forms of Life & Practice (2011-2013)

7.参与英国经济社会理事会项目:State Strategies of Governance in Global Biomedical Innovation: the Impact of China and India (I) (2010-2011)

8.参与奥地利科学研究部基因组项目:Biomarker: Towards the Governance of an Emerging Medical Technology(2009-2012)

9.参与欧盟REMEDIE项目:Regenerative Medicine in Europe: Emerging Needs and Challenges in a Global Context (2008-2011)

10.参与欧盟BIONET项目:Ethical Governance of Biological and Biomedical Research: Chinese and European Cooperation (2006-2009)

 

(英文)

Name

Haidan Chen

Year of birth 

1979年

Research fields

Bioethics; Science, Technology and Society (STS)

E-mail

chenhaidan@bjmu.edu.cn

Degree

Ph.D

Title

Associate Professor with Tenure

Education experience

Ph.D  Zhejiang University (2009)

 

 

Work experience

School of Humanities, Zhejiang University (2009-2012, Postdoctor)

Asia Research Institute, National University of Singapore (2012-2013, Postdoctor)

College of Humanities and Development Studies, China Agricultural University (2013-2019, Associate Professor, Professor)

Stanford Center for Biomedical Ethics (2016-2017, Fulbright Visiting Scholar)

 

 

 

 

Academic community

Science, Technology and Society Journal, Collaborating Editor, (2013-2017)

East Asian Science, Technology and Society: an International Journal, Advisory Board (2015- ), Book Review Editor (2012-2014)

Bioethics Committee of the Chinese Society for Dialectics of Nature / Philosophy of Nature, Science and Technology, Member (2016-2018), Standing Director (2018- )

Sociology of Science Committee of the Chinese Society for Sociology, Member (2015- )

The Committee of Morality and Ethics in Science, Genetics Society of China, Member (2014- )

Steering Committee of the Asia-Pacific Science, Technology and Society Network (APSTSN), Member (2010-2012)

The Hinxton Group: An International Consortium on Stem Cells, Ethics & Law, Member (2010- )

Courses

Frontiers in Bioethics Seminar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Academic papers

English Papers

1. Margaret Sleeboom-Faulkner*, Haidan Chen and Acim Rosemann, 2018, Regulatory capacity building and the governance of clinical stem cell research in China, Science and Public Policy , 45(3), 416-427.

2.Haidan Chen*, 2017, Reflection on the governance of clinical stem cell research and applications in China, Regenerative Medicine , 12(6),593–597.

3.Lan Lü and Haidan Chen*, 2016, Chinese Public’s Risk Perceptions of Genetically Modified Food: From the 1990s to 2015. Science, Technology, and Society . 21(1), 110-128.

4.Haidan Chen*, 2016, Book Review People’s Science: Bodies and Rights on the Stem Cell Frontier, New Genetics and Society , 35(1), 97-99.

5.Haidan Chen*, Benny Chan, and Yann Joly, 2015, Privacy and Biobanking in China: A Case of Policy in Transition. Journal of Law, Medicine & Ethics . 43(4), 726-742.

6.Haidan Chen* and Tikki Pang, 2015, Human Genomics in Asia. In: James D. Wright (editor-in-chief), International Encyclopedia of the Social & Behavioral Sciences , 2nd edition, Vol 11. Oxford: Elsevier, pp. 318–322.

7.Haidan Chenand Tikki Pang*, 2015, A Call for Global Governance of Biobanks, Bulletin of World Health Organization , 93, 113-117.

8.Haidan Chen*, 2014, BIONET: Herbert’s Road Toward China, in Valediction for Herbert Gottweis, BioSocieties , 9(4), 475-477.

9.Johannes Starkbaum*, Haidan Chen and Herbert Gottweis, 2014, Publics and Biobanks in China and Europe: A Comparative Perspective. Asia Europe Journal , 12(3), 345-359.

10.Haidan Chen*, 2013, Governing International Biobank Collaboration: A Case Study of China Kadoorie Biobank, Science, Technology and Society , 18(3), 321-338.

11.Gregory Clancey* and Haidan Chen (special issue guest editors), 2013, Asian Biopoleis: Biomedical Research in ‘The Asian Century’,  Science, Technology and Society , 18(3), 267-273.

12.Haidan Chen*, Herbert Gottweis and Johannes Starkbaum, 2013, Public Perceptions of Biobanks in China: A Focus Group Study, Biopreservation and Biobanking, 11(5), 267-271.

13.Haidan Chenand Herbert Gottweis*, 2013, Stem Cell Treatment in China: Rethinking the Patient Role in the Global Bio-Economy, Bioethics , 27(4), 194-207.

14.Ayo Wahlberg*, Christoph Rehmann-Sutter, Margaret Sleeboom-Faulkner, Guangxiu Lu, Ole D?ring, Yali Cong, Alicja Laska-Formejster, Jing He, Haidan Chen, Herbert Gottweis and Nikolas Rose, 2013, From Global Bioethics to Ethical Governance of Biomedical Research Collaborations, Social Science and Medicine , 98, 293-300.

15.Christian Haddad*, Haidan Chen and Herbert Gottweis, 2013, Unruly Objects: Novel Innovation Paths and Their Regulatory Challenge. In Andrew Webster (editor), The Global Dynamics of Regenerative Medicine: A Social Science Critique , Palgrave Macmillan, pp. 88-117.

16.Herbert Gottweis*, Haidan Chen and Johannes Starkbaum, 2011, Biobanks and the Phantom Public, Human Genetics , 130(3), 433-440.

17.Haidan Chen*, 2011, Cord Blood Banking in China: Public and Private Tensions, East Asian Science, Technology and Society: an International Journal , 5, 329-339.

18.Haidan Chen*, 2009, Stem Cell Governance in China: From Bench to Bedside? New Genetics and Society , 28(3), 267-282.

Chinese Papers

19.Haidan Chen*, 2019, Ethical Debates and the Governance of Science and Technology: A Case Study of Embryo and Stem Cell Research in the UK, Journal of Dialectics of Nature , forthcoming.

20.Haidan Chen*, 2018, Review and Prospect of China’s Policies for Clinical Stem Cell Research, Journal of Dialectics of Nature , 40(3), 81-86.

21.Haidan Chen*, 2013, Stem Cell Governance in China: From the Perspective of Co-production, Journal of Dialectics of Nature , 35(2), 112-117.

22.Xiaoming Sheng* and Haidan Chen, 2007, Survey on Epistemic Culture through Laboratory Studies, Studies in Science of Science , 25(6), 1041-1046.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research projects

National projects

1.Ethical and Social Issues of Personalized Medicine (2015-2018), funded by the National Social Science Foundation of China, PI

2.Governance of Translational Medicine (2013-2016), funded by the Chinese Universities Scientific Fund, PI

3.Governance of Biobanks in China (2011-2013), funded by the Humanities and Social Sciences Research Programs of the Ministry of Education, PR.C, PI

4.Biobank Governance (2010-2012), funded by the China Postdoctoral Science Foundation, PI

International projects

1.Regulation of International Direct-to-Participant Genomic Research (2018-2021), funded by the National Institutes of Health (NIH), collaborator

2.Biobanks in Developing Countries: Needs and Challenges for Global Governance (2014-2015), funded by the Lee Kuan Yew School of Public Policy, National University of Singapore, Co-PI with Tikki Pang

3.Harmonizing Privacy Laws to Enable International Biobank Research (2014-2016), funded by the National Institutes of Health (NIH), collaborator

4.Rising Powers II: State Strategies of Governance in Global Biomedical Innovation: The Impact of China and India (2012-2015), funded by the Economic and Social Research Council (ESRC), collaborator

5.Eco-Health Assessment on Poultry Production Clusters (PPCs) for the Livelihood Improvement of Small-scale Poultry Producers (2011-2014), funded by International Development Research Center (IDRC), collaborator

6.Asian Biopoleis: Biotechnology & Biomedicine as Emergent Forms of Life & Practice, supported by the Singapore Ministry of Education and National University of Singapore (2010-2013), collaborator

7.Rising Powers I: State Strategies of Governance in Global Biomedical Innovation: the Impact of China and India (2012-2015), funded by the Economic and Social Research Council (ESRC), collaborator

8.Biomarker: Towards the Governance of an Emerging Medical Technology, funded by the Genome Program GEN-AU of the Austrian Federal Ministry of Science and Research (2009-2012), collaborator

9.European Union 7th Research Framework project REMEDiE: Regenerative Medicine in Europe: Emerging Needs and Challenges in a Global Context (2008-2011), collaborator

10.European Union 6th Research Framework project BIONET: Ethical Governance of Biological and Biomedical Research: Chinese and European Cooperation (2006-2009), junior research fellow